Science Explorer Back to mapMap

Most cited papers in Electroconvulsive Therapy Studies

What are the most cited papers in Electroconvulsive Therapy Studies?

The most cited paper in Electroconvulsive Therapy Studies is "Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments" (Masashi Nibuya, Shigeru Morinobu, R. S. Duman, 1995), with 2,117 citations. Next come "The Serotonin Syndrome" (1,829) and "Development and Validation of a Screening Instrument for Bipolar Spectrum Disorder: The Mood Disorder Questionnaire" (1,544).

Showing 50 of 100 papers. Every paper with more than 557 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments Masashi Nibuya, Shigeru Morinobu, R. S. Duman · Journal of Neuroscience Open access Nov 1995 2,117
2 The Serotonin Syndrome Edward W. Boyer, Michael Shannon · New England Journal of Medicine 17 Mar 2005 1,829
3 Development and Validation of a Screening Instrument for Bipolar Spectrum Disorder: The Mood Disorder Questionnaire Robert M. A. Hirschfeld, Janet B. W. Williams, Robert L. Spitzer et al. · American Journal of Psychiatry Nov 2000 1,544
4 Clinical research with transcranial direct current stimulation (tDCS): Challenges and future directions ANDRÉ RUSSOWSKY BRUNONI, Michael Andreas Nitsche, Nadia Bolognini et al. · Brain stimulation Open access Apr 2011 1,476
5 Positron Emission Tomographic Analysis of Central D1 and D2 Dopamine Receptor Occupancy in Patients Treated With Classical Neuroleptics and Clozapine Lars Farde · Archives of General Psychiatry Jul 1992 1,425
6 Effectiveness of theta burst versus high-frequency repetitive transcranial magnetic stimulation in patients with depression (THREE-D): a randomised non-inferiority trial Daniel M. Blumberger, Fidel Vila‐Rodriguez, Kevin E. Thorpe et al. · The Lancet Apr 2018 1,365
7 11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study) Jari Tiihonen, Jouko K Lönnqvist, Kristian Wahlbeck et al. · The Lancet 12 Jul 2009 1,362
8 The serotonin syndrome Harvey A. Sternbach · American Journal of Psychiatry Jun 1991 1,353
9 Predictors of Relapse Following Response From a First Episode of Schizophrenia or Schizoaffective Disorder Delbert G. Robinson, Margaret G. Woerner, Jose Ma. J. Alvir et al. · Archives of General Psychiatry Mar 1999 1,337
10 Evidence-based guidelines for treating bipolar disorder: Revised third edition recommendations from the British Association for Psychopharmacology GM Goodwin et al. · Journal of Psychopharmacology Open access 15 Mar 2016 1,317
11 Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013 Lakshmi N. Yatham et al. · Bipolar Disorders Open access 12 Dec 2012 1,221
12 Cognitive Function Across Manic or Hypomanic, Depressed, and Euthymic States in Bipolar Disorder Anabel Martínez‐Arán, Eduard Vieta, María Reinares et al. · American Journal of Psychiatry 30 Jan 2004 1,112
13 Catatonia. I. Rating scale and standardized examination G. Bush, Max Fink, Georgios Petrides et al. · Acta Psychiatrica Scandinavica Feb 1996 1,101
14 Sequenced treatment alternatives to relieve depression (STAR*D): rationale and design Augustus John Rush et al. · Controlled Clinical Trials Feb 2004 1,096
15 The Spectrum of Rhabdomyolysis Patricia A. Gabow, William D. Kaehny, Stephen P. Kelleher · Medicine May 1982 1,089
16 A Meta-analysis of the Efficacy of Second-Generation Antipsychotics John M. Davis, Nancy Chen, Ira D. Glick · Archives of General Psychiatry Review Jun 2003 1,043
17 The Hunter Serotonin Toxicity Criteria: simple and accurate diagnostic decision rules for serotonin toxicity E.J.C. Dunkley, Geoffrey Kennedy Isbister, David William Sibbritt et al. · QJM 18 Aug 2003 1,035
18 Schizophrenia Sameer Jauhar, Mandy Johnstone, Peter J McKenna · The Lancet Open access 2022 1,026
19 Increased baseline occupancy of D 2 receptors by dopamine in schizophrenia Anissa Abi‐Dargham, Janine Rodenhiser, DAVID J. PRINTZ et al. · Proceedings of the National Academy of Sciences Open access 5 Jul 2000 1,020
20 Medication Augmentation after the Failure of SSRIs for Depression Madhukar H. Trivedi, Maurizio Fava, Stephen R. Wisniewski et al. · New England Journal of Medicine Open access 22 Mar 2006 1,016
21 Cognitive Therapy vs Medications in the Treatment of Moderate to Severe Depression Robert J. DeRubeis, Steven D. Hollon, Jay D. Amsterdam et al. · Archives of General Psychiatry Apr 2005 997
22 Modification of the Clinical Global Impressions (CGI) scale for use in bipolar illness (BP): the CGI-BP Melissa K. Spearing, Robert M. Post, Gabriele S. Leverich et al. · Psychiatry Research Dec 1997 981
23 Subthalamic Nucleus Stimulation in Severe Obsessive–Compulsive Disorder Luc Mallet et al. · New England Journal of Medicine Open access 12 Nov 2008 974
24 A meta-analysis of cognitive deficits in euthymic patients with bipolar disorder Lucy J. Robinson, Jill Maria Thompson, Peter Gallagher et al. · Journal of Affective Disorders Review 8 Mar 2006 962
25 The Syndrome of Inappropriate Antidiuresis David H. Ellison, Tomás Berl · New England Journal of Medicine 16 May 2007 949
26 Effects of Stimulus Intensity and Electrode Placement on the Efficacy and Cognitive Effects of Electroconvulsive Therapy Harold A. Sackeïm, Joan Prudic, D. P. Devanand et al. · New England Journal of Medicine Open access 25 Mar 1993 944
27 The 2009 Schizophrenia PORT Psychopharmacological Treatment Recommendations and Summary Statements Robert W. Buchanan, Julie A. Kreyenbuhl, Deanna L. Kelly et al. · Schizophrenia Bulletin Open access 2 Dec 2009 918
28 Efficacy of Divalproex vs Lithium and Placebo in the Treatment of Mania Charles L. Bowden · JAMA 23 Mar 1994 917
29 Bench-to-bedside review: Rhabdomyolysis -- an overview for clinicians. Ana Laura Huerta-Alardin, Joseph Varón, Paul Ellis Marik · Critical Care Open access 2004 910
30 Natural History and Expansive Clinical Profile of Stress (Tako-Tsubo) Cardiomyopathy Scott W. Sharkey, Denise C. Windenburg, John R. Lesser et al. · Journal of the American College of Cardiology Open access 2010 908
31 Atypical Antipsychotics: Mechanism of Action Philip M. Seeman · The Canadian Journal of Psychiatry Open access Feb 2002 905
32 Olanzapine versus haloperidol in the treatment of schizophrenia and schizoaffective and schizophreniform disorders: results of an international collaborative trial Gary D. Tollefson, Charles M. Beasley, P.V. Tran et al. · American Journal of Psychiatry Apr 1997 901
33 A Randomized, Double-Blind, Placebo-Controlled Trial of Quetiapine in the Treatment of Bipolar I or II Depression Joseph R. Calabrese, Paul E. Keck, Wayne Macfadden et al. · American Journal of Psychiatry 30 Jun 2005 886
34 A Canadian Multicenter Placebo-Controlled Study of Fixed Doses of Risperidone and Haloperidol in the Treatment of Chronic Schizophrenic Patients Guy Chouinard, BARRY D. JONES, Gary J. Remington et al. · Journal of Clinical Psychopharmacology Feb 1993 881
35 Induction of Late LTP-Like Plasticity in the Human Motor Cortex by Repeated Non-Invasive Brain Stimulation Katia Karina Monte-Silva, Min‐Fang Kuo, Silvia Hessenthaler et al. · Brain stimulation Open access 2 Jun 2012 880
36 Re-evaluating the prevalence of and diagnostic composition within the broad clinical spectrum of bipolar disorders Hagop Souren Akiskal, Marc Louis Bourgeois, Jules Angst et al. · Journal of Affective Disorders Sep 2000 878
37 Nucleus Accumbens Deep Brain Stimulation Decreases Ratings of Depression and Anxiety in Treatment-Resistant Depression Bettina Heike Bewernick, René Hurlemann, Andreas Matusch et al. · Biological Psychiatry 16 Nov 2009 877
38 Treatment of bipolar disorder John Geddes, David J. Miklowitz · The Lancet Open access May 2013 839
39 Cortical abnormalities in bipolar disorder: an MRI analysis of 6503 individuals from the ENIGMA Bipolar Disorder Working Group for the ENIGMA Bipolar Disorder Working Group et al. · Molecular Psychiatry Open access124 authors 2 May 2017 838
40 Drugs, Neurotransmitters, and Schizophrenia Solomon H. Snyder, Shailesh P. Banerjee, Henry I. Yamamura et al. · Science 21 Jun 1974 836
41 Effects of antipsychotics, antidepressants and mood stabilizers on risk for physical diseases in people with schizophrenia, depression and bipolar disorder Christoph Ulrich Correll, Johan Detraux, Jan De Lepeleire et al. · World Psychiatry Open access Jun 2015 833
42 A Prospective, Randomized, Double-blind Comparison of Bilateral and Right Unilateral Electroconvulsive Therapy at Different Stimulus Intensities Harold A. Sackeïm, Joan Prudic, D. P. Devanand et al. · Archives of General Psychiatry May 2000 812
43 Treatment‐resistant depression: definition, prevalence, detection, management, and investigational interventions Roger S. McIntyre et al. · World Psychiatry Open access 15 Sep 2023 799
44 Neuroleptics and the Natural Course of Schizophrenia Richard Jed Wyatt · Schizophrenia Bulletin 1991 797
45 A Randomized Trial on the Efficacy of Group Psychoeducation in the Prophylaxis of Recurrences in Bipolar Patients Whose Disease Is in Remission Francesc Colom, Eduard Vieta, Anabel Martínez‐Arán et al. · Archives of General Psychiatry Apr 2003 797
46 Treatment-resistant depression: therapeutic trends, challenges, and future directions Alharbi Alharbi · Patient Preference and Adherence Open access May 2012 796
47 THE MECHANISM OF ACTION OF FOSFOMYCIN (PHOSPHONOMYCIN) Frederick M. Kahan, Jean S. Kahan, Patrick J. Cassidy et al. · Annals of the New York Academy of Sciences May 1974 790
48 Olanzapine versus Placebo and Haloperidol Charles M. Beasley, Gary D. Tollefson, P. Tran et al. · Neuropsychopharmacology Feb 1996 789
49 Increased neurogenesis in a model of electroconvulsive therapy Torsten M. Madsen, Alexandra Treschow, Johan Bengzon et al. · Biological Psychiatry Jun 2000 768
50 Relapse and impairment in bipolar disorder Michael J Gitlin, Joel David Swendsen, Tamar Heller et al. · American Journal of Psychiatry Nov 1995 765

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for a field when OpenAlex files it under one of the field's topics; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.